HSA
DTIL icon

HBK Sorce Advisory’s Precision BioSciences DTIL Stock Holding History

HBK Sorce Advisory’s Portfolio DTIL Stock Details DTIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$78.2K Buy
10,164
+130
+1% +$600 ﹤0.01% 632
2025
Q4 		$38.1K Buy
+10,034
New +$57K ﹤0.01% 615
2024
Q1 		– Sell
-450
Closed -$4.93K – 612
2023
Q4 		$4.93K Hold
450
– – ﹤0.01% 567
2023
Q3 		$4.61K Buy
+450
New +$6.92K ﹤0.01% 563

Other funds holding DTIL

OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Aberdeen Group
Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return
EAM
Empery Asset Management New York $83M AUM
BL
Bleichroeder LP New York $579M AUM 94.36% 1-Year Est. Return
BFM
Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AAA
Affinity Asset Advisors New York $1.94B AUM 374.45% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return

HBK Sorce Advisory's DTIL Position: Q1 2026 in Review

HBK Sorce Advisory increased its Precision BioSciences (DTIL) stake by 1.3% in Q1 2026, buying an estimated $600 and bringing the position to 10,164 shares worth $78.2K. The position accounts for ﹤0.01% of the portfolio, ranked #632.

HBK Sorce Advisory first reported a position in DTIL in Q3 2023 and has held it in 4 quarters since. 78 funds tracked by Wall St. Rank hold DTIL as of Q1 2026.

  • HBK Sorce Advisory held 10,164 shares of Precision BioSciences worth $78.2K as of Q1 2026.
  • HBK Sorce Advisory bought 130 Precision BioSciences shares in Q1 2026, an estimated $600.
  • Precision BioSciences made up ﹤0.01% of HBK Sorce Advisory's portfolio in Q1 2026, its #632 holding.
  • HBK Sorce Advisory first reported a position in Precision BioSciences in Q3 2023 and has held it in 4 quarters since.
  • 78 funds tracked by Wall St. Rank held Precision BioSciences as of Q1 2026.

Based on HBK Sorce Advisory's 13F filing for Q1 2026, filed 11 May 2026.